نمایش پرونده ساده آیتم

dc.contributor.authorEbrahimi, E
dc.contributor.authorAkbarzadeh, A
dc.contributor.authorAbbasi, E
dc.contributor.authorKhandaghi, AA
dc.contributor.authorAbasalizadeh, F
dc.contributor.authorDavaran, S
dc.date.accessioned2018-08-26T07:31:29Z
dc.date.available2018-08-26T07:31:29Z
dc.date.issued2016
dc.identifier10.3109/21691401.2014.944646
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47226
dc.description.abstractNew drug delivery systems delivered the active molecules to the target site in a definite manner to produce the desired effects without disturbing the delicate bio-environment. The Fe3O4 magnetic nanoparticles were prepared by chemical precipitation of Fe salts in the ratio of 1:2 under alkaline and inert condition. PLGA-PEG(1000) triblock copolymer was synthesized by ring-opening polymerization. The properties of this copolymer were characterized using Fourier transform infrared spectroscopy. In addition, the resulting particles were characterized by X-ray powder diffraction, scanning electron microscopy, and vibrating sample magnetometry. The in vitro doxorubicin (DOX) release profiles were obtained by representing the percentage of DOX release. In this report, we used this new method to fabricate PEGylated PLGA particles, and examined the anticancer agent DOX.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectbiomedical applications
dc.subjectdoxorubicin
dc.subjectPLGA
dc.subjectpolymeric nanoparticles
dc.titleNovel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG(1000) copolymer
dc.typeArticle
dc.citation.volume44
dc.citation.issue1
dc.citation.spage290
dc.citation.epage297
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.3109/21691401.2014.944646


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم